FEATURE STORY
● The landscape of early clinical gene therapies outside oncology
BASIC SCIENCE
● Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL
CLINICAL TRIALS/DATA
● ATL1102 for DMD commencement of European regulatory interactions
● UniQure stays a step ahead in hemophilia B
FINANCIAL DATA
● Passage Bio Closes $110 Million Series B Financing
● Achilles Therapeutics raises 100 M£ in oversubscribed series B financing
● Nkarta Therapeutics raises $114 Million in Series B financing to advance multiple programs into clinical trial
M&A/AGREEMENTS
● Phio Pharmaceuticals announces research collaboration with Carisma Therapeutics to evaluate its self-delivering RNAi technology
● Vertex to acquire Semma Therapeutics with a goal of developing curative cell-based treatments for type 1 diabetes
● Sumitomo Dainippon buys five Roivant companies for $3 Billion with option to buy six more
To read the full articles: Trend Chart on Innovative Bioindustries September 12th
Trend Chart on Innovative Bioindustries – September 12th
FEATURE STORY
● The landscape of early clinical gene therapies outside oncology
BASIC SCIENCE
● Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL
CLINICAL TRIALS/DATA
● ATL1102 for DMD commencement of European regulatory interactions
● UniQure stays a step ahead in hemophilia B
FINANCIAL DATA
● Passage Bio Closes $110 Million Series B Financing
● Achilles Therapeutics raises 100 M£ in oversubscribed series B financing
● Nkarta Therapeutics raises $114 Million in Series B financing to advance multiple programs into clinical trial
M&A/AGREEMENTS
● Phio Pharmaceuticals announces research collaboration with Carisma Therapeutics to evaluate its self-delivering RNAi technology
● Vertex to acquire Semma Therapeutics with a goal of developing curative cell-based treatments for type 1 diabetes
● Sumitomo Dainippon buys five Roivant companies for $3 Billion with option to buy six more
To read the full articles: Trend Chart on Innovative Bioindustries September 12th
COMMENTS ARE OFF THIS POST